FDA: Pfizer Drug Can Stay on Market

Merck higher on news it would consider selling Vioxx again; MCI higher on renewed Qwest interest; plus more of Friday's stocks in the news

Pfizer (PFE ) was higher as the FDA panel votes to allow Celebrex Cox-2 to remain on market. S&P reiterates hold..

To continue reading this article you must be a Bloomberg Professional Service Subscriber.